Postavení preparátu ZD 1839 (IRESSA) v léčbě nemocných s pokročilým nemalobuněčným karcinomem (NSCLC)
| Title in English | ZD 1839 (IRESSA) in treatment of patients with advanced non-small cell lung cancer (NSCLC) |
|---|---|
| Authors | |
| Year of publication | 2004 |
| Type | Article in Proceedings |
| Conference | XVIII. brněnské onkologieké dny a XVIII. konference pro sestry a laboranty - edukační sborník |
| MU Faculty or unit | |
| Citation | |
| Field | Pneumology |
| Keywords | gefitinib; IRESSA; treatment od non-small cell lung cancer; biological treatment of lung cancer |
| Description | Biological or targeted therapy of non-small cell lung cancer is a recent promising treatment option for pacients where standard anti-cancer drug therapy fails. The authors present their own experience with 58 patients treated in 2004-2004. |
| Related projects: |